Ogivri

Active Ingredient(s): Trastuzumab-dkst
FDA Approved: * December 1, 2017
Pharm Company: * MYLAN GMBH
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Ogivri Overview

Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer.[3] Specifically it is used for breast cancer that is HER2 receptor positive.[3] It may be used by itself or together with other chemotherapy medication.[3] Trastuzumab is given by slow injection into a vein and injection just under the skin.[3][4] Common side effects include fever, infection, cough, headache, trouble sleeping, and rash.[3] Other severe side effects include hear...

Read more Ogivri Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Trastuzumab

Recent Ogivri Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Trastuzumab-dkst
  • Injection: 420mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Trastuzumab-dkst or a similar ingredient: (1 result)





Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. Site content is Copyright © 2005-2018 MedsChat.com and is protected under U.S. and International Copyright laws. All Rights Reserved. This page was last updated on 23 June 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® and The People's Medicine Community® are registered trademarks of Limelight Innovations L.L.C.